Get started
Author

Jean‐Claude Barbare

Observed names: BARBARE, JEAN-CLAUDE, Barbare, Jean-Claude, Claude Barbare, J C Barbare, J. Barbare, J. C. Barbare, J.-C. Barbare, J.C. Barbare, Jean Claude Barbare, Jean-Claude Barbare, Jean-Claude Barbare, Jean‑Claude Barbare
Observed institutions: Inserm, Institut Gustave Roussy, Centre Hospitalier Universitaire Amiens-Picardie, Assistance Publique – Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Hôpital Saint-Antoine, Centre Hospitalier Universitaire de Reims, Centre Eugène Marquis, Centre Hospitalier Compiègne-Noyon, Association Nationale des Hépato-Gastroentérologues des Hôpitaux Généraux de France, Fédération Francophone de Cancérologie Digestive, Hôpital Robert-Debré, Centre Hospitalier Universitaire de Clermont-Ferrand, Hôpital Saint Eloi, Institut National du Cancer, Cancéropôle Nord-Ouest, Université Paris Descartes, Université de Picardie Jules Verne
ORCID: 0000-0001-8228-4542
Observed ORCID: 0000-0001-8228-4542
OpenAlex ID: A5031662794
Iron‐dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
2013 · Christophe Louandre, Zakaria Ezzoukhry, et al. · International Journal of Cancer · 598
The retinoblastoma (Rb) protein regulates ferroptosis induced by sorafenib in human hepatocellular carcinoma cells
2014 · Christophe Louandre, Ingrid Marcq, et al. · Cancer Letters · 372
Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma
2016 · Chloé Sauzay, Alexandra Petit, et al. · Clinica Chimica Acta · 291
EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
2012 · Zakaria Ezzoukhry, Christophe Louandre, et al. · International Journal of Cancer · 177
Metallothionein-1 as a biomarker of altered redox metabolism in hepatocellular carcinoma cells exposed to sorafenib
2016 · Aline Houessinon, Catherine François, et al. · Molecular Cancer · 137
PDF
Randomized Controlled Trial of Tamoxifen in Advanced Hepatocellular Carcinoma
2005 · Jean-Claude Barbare, Olivier Bouché, et al. · Journal of Clinical Oncology · 133
Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country
2016 · Nathalie Goutté, Philippe Sogni, et al. · Journal of Hepatology · 118
PDF
Prognosis of advanced hepatocellular carcinoma: comparison of three staging systems in two French clinical trials
2008 · S. Collette, F. Bonnetain, et al. · Annals of Oncology · 87
New biological perspectives for the improvement of the efficacy of sorafenib in hepatocellular carcinoma
2014 · Antoine Galmiche, Bruno Chauffert, et al. · Cancer Letters · 85
Treatment of severe alcoholic hepatitis by infusion of insulin and glucagon: A multicenter sequential trial
1992 · Jean-Claude Trinchet, Beverley Balkau, et al. · Hepatology · 75
PDF
The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma
2012 · Momar Diouf, Thomas Filleron, et al. · Journal of Hepatology · 66
Quality of life as a prognostic factor of overall survival in patients with advanced hepatocellular carcinoma: results from two French clinical trials
2008 · Franck Bonnetain, Xavier Paoletti, et al. · Quality of Life Research · 66
Hepatocellular Carcinoma (HCC): An Update
2007 · Philippe Rougier, Emmanuel Mitry, et al. · Seminars in Oncology · 66
Treatment of advanced hepatocellular carcinoma with long-acting octreotide: A phase III multicentre, randomised, double blind placebo-controlled study
2009 · Jean-Claude Barbare, Olivier Bouché, et al. · European Journal of Cancer · 64
BAD, a Proapoptotic Member of the BCL2 Family, Is a Potential Therapeutic Target in Hepatocellular Carcinoma
2010 · Antoine Galmiche, Zakaria Ezzoukhry, et al. · Molecular Cancer Research · 50
The Influence of Vasoactive Agents on Metabolic Activity of the Liver in Cirrhosis: A Study of the Effects of Posterior Pituitary Extract, Vasopressin, and Somatostatin†
1984 · Jean-Claude Barbare, Raoul Poupon, et al. · Hepatology · 49
PDF
Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials
2018 · Thomas Aparicio, Michel Ducreux, et al. · European Journal of Cancer · 46
PDF
Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial
2019 · Boris Guiu, Patrick Chevallier, et al. · Radiology · 41
Intrinsic hepatic clearance and child-turcotte classification for assessment of liver function in cirrhosis
1985 · J.C. Barbare, R.E. Poupon, et al. · Journal of Hepatology · 41
Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI)
2021 · Jean Frédéric Blanc, Audrey Debaillon-Vesque, et al. · Clinics and Research in Hepatology and Gastroenterology · 36
Medical treatments for hepatocellular carcinoma (HCC): what’s next?
2006 · J. Taieb, J.C. Barbare, et al. · Annals of Oncology · 34
Prevalence and risk factors of bacteriuria in cirrhotic patients: a prospective case-control multicenter study in 244 patients
1999 · Jean-François Cadranel, Jacques Denis, et al. · Journal of Hepatology · 33
Development and validation of a new prognostic score of death for patients with hepatocellular carcinoma in palliative setting
2010 · Caroline Tournoux-Facon, Xavier Paoletti, et al. · Journal of Hepatology · 30
Prevalence of hepatitis C infection and risk factors in hospitalized diabetic patients: results of a cross-sectional study
2008 · Jean-François Cadranel, Vincent Di Martino, et al. · European Journal of Gastroenterology & Hepatology · 29
Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C
2019 · Charlotte E. Costentin, Philippe Sogni, et al. · Digestive Diseases and Sciences · 27
Works count: 105
Citation count: 2,997
H-index: 26
I10-index: 38
Year
Topic
Type